126 related articles for article (PubMed ID: 10024917)
1. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome.
Chin K; Kita H; Noguchi T; Otsuka N; Tsuboi T; Nakamura T; Shimizu K; Mishima M; Ohi M
QJM; 1998 Sep; 91(9):627-33. PubMed ID: 10024917
[TBL] [Abstract][Full Text] [Related]
2. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
[TBL] [Abstract][Full Text] [Related]
3. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Chin K; Shimizu K; Nakamura T; Narai N; Masuzaki H; Ogawa Y; Mishima M; Nakamura T; Nakao K; Ohi M
Circulation; 1999 Aug; 100(7):706-12. PubMed ID: 10449691
[TBL] [Abstract][Full Text] [Related]
4. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.
Resta O; Guido P; Picca V; Sabato R; Rizzi M; Scarpelli F; Sergi M
Respir Med; 1998 Jun; 92(6):820-7. PubMed ID: 9850365
[TBL] [Abstract][Full Text] [Related]
5. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea.
Sériès F; Marc I; Cormier Y; La Forge J
Eur Respir J; 1994 Oct; 7(10):1776-81. PubMed ID: 7828684
[TBL] [Abstract][Full Text] [Related]
6. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.
Chin K; Ohi M; Kita H; Noguchi T; Otsuka N; Tsuboi T; Mishima M; Kuno K
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1972-6. PubMed ID: 8665063
[TBL] [Abstract][Full Text] [Related]
7. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome.
Chin K; Ohi M
Respirology; 1998 Jun; 3(2):139-43. PubMed ID: 9692524
[TBL] [Abstract][Full Text] [Related]
8. [Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].
Hollandt JH; Kuhl S; Siegert R
Laryngorhinootologie; 1997 Sep; 76(9):550-3. PubMed ID: 9417184
[TBL] [Abstract][Full Text] [Related]
9. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure.
Veale D; Pépin JL; Wuyam B; Lévy PA
Eur Respir J; 1996 Oct; 9(10):2122-6. PubMed ID: 8902477
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of demand of positive airway pressure therapy for treating obstructive sleep apnea syndrome].
García Arroyo I; Terán Santos J; Cordero Guevara J; Rodríguez Pascual L
Arch Bronconeumol; 1999 May; 35(5):208-13. PubMed ID: 10378047
[TBL] [Abstract][Full Text] [Related]
11. [Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index].
Lacassagne L; Didier A; Doussau S; Murris-Espin M; Birot P; Charlet JP; Thach KS; Tiberge M; Paoli JR; Pessey JJ; Léophonte P
Rev Mal Respir; 2000 Apr; 17(2):467-74. PubMed ID: 10859765
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnoea syndrome.
Lojander J; Brander PE; Ammälä K
Acta Otolaryngol; 1999; 119(4):497-502. PubMed ID: 10445068
[TBL] [Abstract][Full Text] [Related]
13. nCPAP treatment interruption in OSA patients.
Fiz JA; Abad J; Ruiz J; Riera M; Izquierdo J; Morera J
Respir Med; 1998 Jan; 92(1):28-31. PubMed ID: 9519221
[TBL] [Abstract][Full Text] [Related]
14. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea.
Hers V; Liistro G; Dury M; Collard P; Aubert G; Rodenstein DO
Eur Respir J; 1997 May; 10(5):973-6. PubMed ID: 9163633
[TBL] [Abstract][Full Text] [Related]
15. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome.
Shimizu K; Chin K; Nakamura T; Masuzaki H; Ogawa Y; Hosokawa R; Niimi A; Hattori N; Nohara R; Sasayama S; Nakao K; Mishima M; Nakamura T; Ohi M
Thorax; 2002 May; 57(5):429-34. PubMed ID: 11978920
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome.
Nakamura T; Chin K; Shimizu K; Kita H; Mishima M; Nakamura T; Ohi M
Sleep; 2001 Aug; 24(5):545-53. PubMed ID: 11480652
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea.
Mar J; Rueda JR; Durán-Cantolla J; Schechter C; Chilcott J
Eur Respir J; 2003 Mar; 21(3):515-22. PubMed ID: 12662011
[TBL] [Abstract][Full Text] [Related]
18. [Predictive factors of minimally effective nCPAP ventilation in treatment of obstructive sleep apnea?].
Teschler H; Hoheisel G; Wagner B; Schumann H; Konietzko N
Med Klin (Munich); 1995 Jun; 90(6):330-7. PubMed ID: 7637664
[TBL] [Abstract][Full Text] [Related]
19. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome.
Pieters T; Collard P; Aubert G; Dury M; Delguste P; Rodenstein DO
Eur Respir J; 1996 May; 9(5):939-44. PubMed ID: 8793455
[TBL] [Abstract][Full Text] [Related]
20. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study.
Kiely JL; Murphy M; McNicholas WT
Eur Respir J; 1999 May; 13(5):1086-90. PubMed ID: 10414408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
